March 6, 2024 · Form 4 insider transaction
Gentry Leesa bought 190,000 shares of RenovoRx, Inc., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents 10-year incentive stock options to purchase 190,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning to vest on March 1, 2024.